Beta Bionics has hired Steven Russell as chief medical officer. The change comes as Beta Bionics works to secure US Food and Drug Administration (FDA) clearance for its pocket-sized, wearable autonomous insulin dosing device, iLet.
Russell joined Massachusetts General Hospital in 2001 and has held the role of attending physician for most of his time at the organization. Russell also worked from 2006 at Harvard Medical School, where he spent the past five years as associate professor of medicine. Russell has kept his Harvard faculty appointment and will work at MGH Diabetes Associates part time.
Beta Bionics designed iLet to enable users to After enter their body weight and leave the device to titrate and infuse insulin. The company claims that the device outperformed a standard of care control arm that included people using hybrid closed loop systems in its pivotal trial.
To read more, CLICK HERE.
